CURING SKIN CONDITIONS TO IMPROVE PATIENTS’ QUALITY OF LIFE
Worldwide, millions of people are bothered by the appearance of vascular lesions, pigmented alternations, wrinkles and scars. These lesions are associated with negative impact on quality of life and may result in psychological morbidity. Laser therapy has proven to be efficient in reducing and resolving many of these unwanted lesions, thereby improving patients’ quality of life.
The ADVATx produces laser energy with wavelengths of 589 and 1319 nm. Currently, it is the only laser device in the 585-595 nm spectrum, having a solid-state medium (crystal) that emits highly vascular-specific yellow light energy without consumables such as dye.
Hemangiomas are tumors of capillary-sized blood vessels most commonly located on the head and neck. They consist of hyperplastic vascular endothelial cells. Hemangiomas may be superficial, deep or both. They usually proliferate (grow fast) during the first year of life, followed by gradual regression and involution during the adolescence. Therefore, common practice seems to be a “wait and see” approach; however, the hemangiomas must be monitored as they can grow and cause permanent physical injury. Laser treatment with 585-595 nm can be very beneficial in proliferating, persisting and ulcerating hemangiomas. All hemangiomas in children should be treated as early as possible to prevent the proliferative phase and its complications.
Three percent of newborns have hemangiomas and in Caucasian infants, the incidence might be as high as 10-12%. Yellow light lasers have proven to be efficient in the treatment of superficial hemangiomas and in the treatment of e.g. strawberry hemangiomas.
ADVATx has FDA and CE clearance for the treatment of Hemangioma.
Cavernous hemangioma. Source: D@nderm.
PORT WINE STAINS
Port wine stains or nevus flammeus is a congenital malformation of capillary-sized superficial dermal blood vessels. The lesions are a result of progressive vascular dilatation. They are the most common vascular malformation, appearing in 0.3% of newborns. They range from a few millimeters to covering big areas of the body. The larger lesions are associated with underlying abnormalities. The lesions grow as the child grows, and become darker through the years. They usually appear on the face; however, they may occur anywhere on the body. They have been associated with marked psychological morbidity, making treatment a necessity in many cases. Significant fading of the lesions is the primary treatment goal. However, the operator must take into consideration that lesions associated with deeper vessels do not respond to laser treatment as well as those associated with superficial vessels.
Oxyhemoglobin is the target chromophore for treatment of port wine stains. Oxyhemoglobin has three primary absorption peaks: 418, 542 and 577 nm. Utilizing laser energy with the wavelength of 589 nm +/- 5 nm have proven its superiority as it maintains vascular specificity, while it makes it possible to penetrate deeper in the skin compared to the shorter wavelengths. If pulse duration is kept shorter than the thermal relaxation time of the target vessels, selective phototermolysis occurs, hereby eliminating thermal damage to surrounding tissue.
Since port wine stains become thicker and darker as the child grows, many advocate for early treatment. There is evidence of a significant reduction in port wine stains in children, whose treatment began before the age of one year.
ADVATx has FDA and CE clearance for the treatment of Port wine stains.
Telangiectasias are permanently dilated small blood vessels consisting of venues, capillaries, or arterioles. They are located in the papillary dermis e.g. in the face or on the legs. The diameter is usually less than 1 mm; however, there may be many lesions in one area, resulting in telangiectatic erythema. Telangiectasias – especially facial telangiectasias – may result in significant cosmetic problems and can be treated efficiently with the ADVATx yellow light laser.
ADVATx has FDA and CE clearance for the treatment of Telangiectasia.
Rosacea is a chronic skin condition that affects all ages and often worsens over time if not treated. Most people with Rosacea are Caucasian and have fair skin. Patients with Rosacea often complain of facial flushing and redness (erythema) typically on the central face across cheeks, nose and forehead.
Rosacea is three times more common in women than in men, and tends to have periotic ups and downs (flares and remissions). Some of the main factors triggering Rosacea are; sun exposure, emotional stress, hot/cold water, and exercise and alcohol consumption.
Telangiectasias are frequently presents and unresponsive to classic topical or systemic treatment. Laser therapy using wavelengths in the 585-595 nm spectrums is well documented to be an effective treatment.
ADVATx has FDA and CE clearance for the treatment of Rosacea.
Rosacea. Source: D@nderm.
OTHER VASCULAR CONDITIONS
Other vascular conditions such as angioma e.g. Spider Angioma (Nevus araenus) or Cherry angioma, Kaposi’s sarcoma and poikiloderma of Civatte have also responded well to yellow light laser treatments.
ADVATx has FDA and CE clearance for the treatment of angioma, Kaposi’s sarcoma and poikiloderma of Civatte.
Poikiloderma civatte. Source: D@nderma.
Spider angioma. Source: D@nderm.
The treatment of vascular lesions is rewarding, as often the results can be seen almost immediately.